$0.0330
-0.00700-17.50%
At close: -
$0.0405
0.0075022.73%
After Hours: 8:00 AM EDT
Comments
Loading...
Syros Pharmaceuticals Earnings Estimates, EPS & Revenue | OTC:SYRS | Benzinga
Syros Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Apr 8
EPS Estimate
$-0.740
Quarterly Revenue Estimate
$450.00K
Annual Revenue
(as of Sep 30)
(as of Sep 30)
$386.00K
Analyze the earnings history of Syros Pharmaceuticals using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| SYRS | Syros Pharmaceuticals | -$0.10 | — | — | — | $0.00 | — | — | — | 05/13/2025 | Get Alert |
| SYRS | Syros Pharmaceuticals | -$2.18 | -$0.74 | — | — | $387.00K | $450.00K | — | — | 04/08/2025 | Get Alert |
| SYRS | Syros Pharmaceuticals | -$1.43 | -$0.72 | -$0.16 | 77.78% | $3.76M | $450.00K | $0.00 | -100.00% | 10/31/2024 | Get Alert |
| SYRS | Syros Pharmaceuticals | -$1.30 | -$0.77 | -$0.59 | 23.38% | $2.83M | $460.00K | $0.00 | -100.00% | 07/31/2024 | Get Alert |
| SYRS | Syros Pharmaceuticals | -$0.85 | -$0.87 | -$0.10 | 88.51% | $2.95M | $720.00K | $0.00 | -100.00% | 05/14/2024 | Get Alert |
| SYRS | Syros Pharmaceuticals | -$0.17 | -$1.14 | -$2.18 | -91.23% | -$754.00K | $2.00M | $387.00K | -80.65% | 03/27/2024 | Get Alert |
| SYRS | Syros Pharmaceuticals | -$3.21 | -$1.14 | -$1.43 | -25.44% | $3.89M | $3.94M | $3.76M | -4.52% | 11/14/2023 | Get Alert |
| SYRS | Syros Pharmaceuticals | -$5.40 | -$1.13 | -$1.30 | — | $6.28M | $3.50M | $2.83M | -19.14% | 08/08/2023 | Get Alert |
| SYRS | Syros Pharmaceuticals | -$3.99 | -$1.09 | -$0.85 | 22.02% | $5.47M | $3.26M | $2.95M | -9.39% | 05/10/2023 | Get Alert |
| SYRS | Syros Pharmaceuticals | -$3.80 | -$1.35 | -$0.17 | 87.41% | $7.80M | — | -$754.00K | — | 03/02/2023 | Get Alert |
| SYRS | Syros Pharmaceuticals | -$4.10 | -$4.01 | -$3.21 | 19.95% | $5.70M | $5.22M | $3.89M | -25.46% | 11/14/2022 | Get Alert |
| SYRS | Syros Pharmaceuticals | -$3.60 | -$3.50 | -$5.40 | -54.29% | $5.16M | $4.57M | $6.28M | 37.33% | 08/09/2022 | Get Alert |
| SYRS | Syros Pharmaceuticals | -$2.30 | -$4.70 | -$4.00 | 14.89% | $4.83M | $4.92M | $5.47M | 11.12% | 05/16/2022 | Get Alert |
| SYRS | Syros Pharmaceuticals | -$6.20 | -$4.70 | -$3.80 | 19.15% | $5.70M | $4.80M | $7.80M | 62.54% | 03/15/2022 | Get Alert |
| SYRS | Syros Pharmaceuticals | -$4.30 | -$4.40 | -$4.10 | 6.82% | $3.83M | $4.49M | $5.70M | 26.88% | 11/05/2021 | Get Alert |
| SYRS | Syros Pharmaceuticals | -$3.80 | -$3.70 | -$3.60 | 2.70% | $3.19M | $4.13M | $5.16M | 24.99% | 08/05/2021 | Get Alert |
| SYRS | Syros Pharmaceuticals | -$3.90 | -$4.60 | -$2.30 | 50.00% | $2.38M | $2.67M | $4.83M | 80.79% | 05/06/2021 | Get Alert |
| SYRS | Syros Pharmaceuticals | -$4.60 | -$5.00 | -$6.20 | -24.00% | $508.00K | $2.70M | $5.70M | 111.04% | 03/04/2021 | Get Alert |
| SYRS | Syros Pharmaceuticals | -$4.70 | -$3.80 | -$4.30 | -13.16% | $558.00K | $2.54M | $3.83M | 50.71% | 11/05/2020 | Get Alert |
| SYRS | Syros Pharmaceuticals | -$4.70 | -$4.00 | -$3.80 | 5.00% | $462.00K | $1.90M | $3.19M | 67.79% | 08/06/2020 | Get Alert |
| SYRS | Syros Pharmaceuticals | -$4.90 | -$4.30 | -$3.90 | 9.30% | $454.00K | $1.62M | $2.38M | 46.85% | 05/07/2020 | Get Alert |
Syros Pharmaceuticals (SYRS) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | 2024-10-31 | $-0.16 | $-0.72 | 77.8 % |
| Q2 | 2024-07-31 | $-0.59 | $-0.77 | 23.4 % |
| Q1 | 2024-05-14 | $-0.10 | $-0.87 | 88.5 % |
| Q4 | 2024-03-27 | $-2.18 | $-1.14 | -91.2 % |
Syros Pharmaceuticals (SYRS) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q3 | 2024-10-31 | $0 | $450.00K | -100.0 % |
| Q2 | 2024-07-31 | $0 | $460.00K | -100.0 % |
| Q1 | 2024-05-14 | $0 | $720.00K | -100.0 % |
| Q4 | 2024-03-27 | $387.00K | $2.00M | -80.7 % |
FAQ
When is Syros Pharmaceuticals (OTCPK:SYRS) reporting earnings?
Syros Pharmaceuticals (SYRS) is scheduled to report earnings on May 13, 2025. The last reported earnings were for reported on October 31, 2024 for Q3.
What were the latest earnings per share (EPS) for Syros Pharmaceuticals (OTCPK:SYRS)?
The Actual EPS was $-0.16, which beat the estimate of $-0.72.
What were Syros Pharmaceuticals’s (OTCPK:SYRS) revenues?
The Actual Revenue was $0K, which missed the estimate of $450K.
Browse earnings estimates, EPS, and revenue on all stocks.